To probe the physiological role of
calsequestrin in excitation-contraction coupling, transgenic mice overexpressing cardiac
calsequestrin were developed. Transgenic mice exhibited 10-fold higher levels of
calsequestrin in myocardium and survived into adulthood, but had severe
cardiac hypertrophy, with a twofold increase in heart mass and cell size. In whole cell-clamped transgenic myocytes, Ca2+ channel- gated Ca2+ release from the sarcoplasmic reticulum was strongly suppressed, the frequency of occurrence of spontaneous or Ca2+ current-triggered "Ca2+ sparks" was reduced, and the spark perimeter was less defined. In sharp contrast,
caffeine-induced Ca2+ transients and the resultant Na+-Ca2+ exchanger currents were increased 10-fold in transgenic myocytes, directly implicating
calsequestrin as the source of the contractile-dependent pool of Ca2+. Interestingly, the
proteins involved in the Ca2+-release cascade (
ryanodine receptor, junctin, and
triadin) were downregulated, whereas Ca2+-uptake
proteins (Ca2+-
ATPase and
phospholamban) were unchanged or slightly increased. The parallel increase in the pool of releasable Ca2+ with overexpression of
calsequestrin and subsequent impairment of physiological Ca2+ release mechanism show for the first time that
calsequestrin is both a storage and a regulatory
protein in the cardiac muscle Ca2+-signaling cascade.
Cardiac hypertrophy in these mice may provide a novel model to investigate the molecular determinants of
heart failure.